Buy Deltasone (Prednisolone 5/10/20/40mg) Online - Foundational Glucocorticoid Corticosteroid for Inflammation and Autoimmune Diseases
Deltasone (Prednisolone 5/10/20/40mg) represents the foundational synthetic glucocorticoid corticosteroid that transformed treatment of inflammatory, autoimmune, allergic, and hematologic diseases across virtually every organ system. Originally developed in the early 1950s and available since 1955, prednisolone remains one of the most widely prescribed medications in medical history due to its broad therapeutic utility across dozens of clinical conditions. Manufactured as bioequivalent generic under WHO-GMP standards, Deltasone provides anti-inflammatory, antiallergic, immunosuppressive, and glucocorticoid actions for conditions ranging from rheumatoid arthritis and bronchial asthma to autoimmune diseases, allergic reactions, skin disorders, and hematologic conditions. Available in four dose strengths (5 mg, 10 mg, 20 mg, 40 mg tablets) enabling careful dose titration from low-dose maintenance to high-dose acute therapy.
Prednisolone works through glucocorticoid receptor activation in target tissue cells. After crossing cell membranes, prednisolone binds cytoplasmic glucocorticoid receptors, translocates to the nucleus, and modulates transcription of hundreds of genes involved in inflammation, immune function, metabolism, and cell survival. This produces suppression of proinflammatory cytokines (TNF-alpha, IL-1, IL-6), inhibition of phospholipase A2 preventing arachidonic acid release, reduced leukocyte migration and function, decreased capillary permeability, lymphocyte apoptosis, and reduced antibody production. Additionally, prednisolone provides glucocorticoid replacement for adrenal insufficiency conditions and produces mineralocorticoid effects at higher doses. Clinical response: anti-inflammatory effect within hours for acute inflammation, peak effect at 4-8 hours, and consistent 12-36 hour biologic activity (elimination half-life 2-4 hours but tissue effects last much longer).
Deltasone serves an extraordinarily broad range of indications. Primary uses include rheumatoid arthritis and other rheumatic diseases; bronchial asthma including status asthmaticus; acute and chronic allergic conditions; autoimmune diseases including systemic lupus erythematosus, dermatomyositis, scleroderma, polyarteritis nodosa; Addison disease and adrenal insufficiency; hematologic conditions including agranulocytosis, thrombocytopenic purpura, hemolytic anemia, various leukemias, lymphogranulomatosis; skin diseases including pemphigus, eczema, psoriasis, exfoliative dermatitis; hepatic conditions; lipoid nephrosis; and many other inflammatory or immune-mediated conditions.
Deltasone dosing varies dramatically by indication and severity (5-100+ mg daily). Peak at 1-2 hours, 2-4 hour plasma half-life (biologic effect 12-36 hours). Manufactured under WHO-GMP standards. Never abruptly discontinue chronic therapy — taper required.
Free prescription
Discrete packaging
Have questions?
Quality Assurance
- Rheumatism: Various rheumatic diseases responding to corticosteroid therapy;
- Systemic Lupus Erythematosus: SLE autoimmune disease management;
- Dermatomyositis: Inflammatory muscle disease with skin involvement;
- Scleroderma: Systemic sclerosis with organ involvement;
- Polyarteritis Nodosa: Nodular periarteritis vasculitis responding to therapy;
- Bronchial Asthma: Acute exacerbations and chronic severe asthma;
- Status Asthmaticus: Severe acute asthma requiring urgent corticosteroid therapy;
- Acute Allergic Conditions: Severe acute allergic reactions requiring systemic corticosteroid;
- Chronic Allergic Conditions: Persistent allergic disorders responding to systemic therapy;
- Addison Disease: Primary adrenocortical insufficiency requiring glucocorticoid replacement;
- Acute Adrenal Insufficiency: Acute adrenocortical failure requiring urgent replacement;
- Adrenogenital Syndrome: Congenital adrenal hyperplasia requiring hormonal management;
- Thrombocytopenic Purpura: Immune thrombocytopenia responding to immunosuppression;
- Hemolytic Anemia: Autoimmune hemolytic anemia responding to therapy;
- Leukemia: Various leukemias including ALL as part of combination chemotherapy;
- Lymphogranulomatosis: Hodgkin lymphoma as part of chemotherapy regimens;
- Pemphigus: Autoimmune bullous skin disease requiring immunosuppression;
- Psoriasis: Severe psoriasis and erythrodermic psoriasis;
- Lipoid Nephrosis: Minimal change nephrotic syndrome responding to corticosteroids.
- Less Inflammation and Pain: Reduces inflammation swelling and pain across affected tissues;
- Better Immune Response Suppression: Suppresses overactive immune response in autoimmune diseases;
- Better Allergic Reaction Control: Acute and chronic allergic conditions respond substantially to therapy;
- Better Autoimmune Disease Management: SLE, dermatomyositis, other autoimmune conditions improve substantially;
- Better Asthma Control: Acute asthma exacerbations and status asthmaticus respond urgently;
- Better Rheumatoid Arthritis Symptoms: Joint pain, swelling, and stiffness improve with anti-inflammatory action;
- Better Skin Condition Relief: Pemphigus, severe eczema, psoriasis, dermatitis improve with therapy;
- Better Blood Disorder Management: Thrombocytopenic purpura, hemolytic anemia, agranulocytosis respond;
- Better Adrenal Insufficiency Replacement: Addison disease and adrenal failure managed with replacement dosing;
- Better Leukemia Combination Therapy: Part of standard chemotherapy regimens for various leukemias;
- Better Lymphoma Treatment: Component of Hodgkin and non-Hodgkin lymphoma chemotherapy;
- Better Nephrotic Syndrome Response: Minimal change nephrotic syndrome responds dramatically;
- Better Broad Therapeutic Utility: Effective across dozens of clinical conditions;
- Better Quick Symptom Relief: Rapid onset makes ideal for acute severe inflammatory conditions;
- Better Systemic Anti Inflammation: Reaches all body tissues for systemic conditions;
- Better Multi Dose Flexibility: 5/10/20/40 mg strengths enable precise titration;
- Better Foundational Corticosteroid Therapy: 70+ years clinical experience since 1955;
- Better Generic Cost: 85-95% lower cost than brand Deltasone makes proven therapy accessible;
- Better Quality of Life: Daily wellbeing improves dramatically as inflammatory and autoimmune disease resolves.
Generic Deltasone (Prednisolone 5 mg) Medication guide:
Deltasone (Prednisolone 5/10/20/40mg) is the foundational synthetic glucocorticoid corticosteroid that transformed treatment of inflammatory, autoimmune, allergic, and hematologic diseases across virtually every organ system. Available since 1955 and representing one of the most widely prescribed medications in medical history, prednisolone provides potent anti-inflammatory, immunosuppressive, antiallergic, and glucocorticoid replacement therapy for dozens of clinical conditions. With over 70 years of accumulated clinical experience, prednisolone remains an essential medication in virtually every medical specialty from rheumatology and pulmonology to hematology, oncology, dermatology, endocrinology, and nephrology. This comprehensive medication guide covers every aspect of Deltasone therapy from corticosteroid physiology through mechanism, pharmacology, safety considerations, drug interactions, patient selection, dosing strategies, tapering protocols, and long-term management recommendations.
💊 Introduction to Deltasone
Deltasone is a prescription oral medication containing prednisolone as its active ingredient. Prednisolone belongs to the class of synthetic glucocorticoid corticosteroids — medications chemically related to natural cortisol (hydrocortisone) but modified to provide enhanced glucocorticoid activity, oral bioavailability, and specific pharmacological properties. The original Deltasone brand was introduced in 1955 as one of the first synthetic corticosteroids revolutionizing treatment of inflammatory and immune-mediated diseases.
The medication is manufactured worldwide by numerous generic pharmaceutical companies. In global markets, particularly in the United Kingdom, Europe, India, and Australia, prednisolone is the preferred systemic glucocorticoid over prednisone (which requires hepatic conversion to prednisolone for activity). Available in four dose strengths (5 mg, 10 mg, 20 mg, and 40 mg oral tablets), Deltasone enables precise dose titration from low-dose maintenance therapy (5 mg daily for chronic conditions) to high-dose acute therapy (60-100 mg daily for severe acute inflammatory conditions) — flexibility essential given the broad range of conditions and severities treated with corticosteroids.
Deltasone occupies a unique position in medicine. Few medications have such broad therapeutic utility — prednisolone is used in rheumatology (rheumatoid arthritis, systemic lupus, polymyalgia rheumatica), pulmonology (asthma exacerbations, COPD, interstitial lung disease), allergy/immunology (severe allergic reactions, angioedema), hematology (autoimmune hemolytic anemia, immune thrombocytopenia, leukemia), oncology (lymphomas, chemotherapy adjunct), dermatology (pemphigus, severe eczema, psoriasis), gastroenterology (inflammatory bowel disease, autoimmune hepatitis), nephrology (nephrotic syndrome, glomerulonephritis), endocrinology (adrenal insufficiency replacement, adrenogenital syndrome), and many other specialties. This unmatched versatility combined with reasonable cost makes prednisolone one of the most important medications in modern medicine.
🔬 Understanding Corticosteroids and Cortisol
Understanding endogenous cortisol physiology is essential for appreciating how Deltasone treats disease and produces its characteristic effects and side effects.
Natural Cortisol and the HPA Axis
Cortisol is the primary endogenous glucocorticoid produced by the adrenal cortex. Its production is regulated by the hypothalamic-pituitary-adrenal (HPA) axis:
HPA axis regulation cascade:
- Hypothalamus releases corticotropin-releasing hormone (CRH)
- CRH stimulates anterior pituitary to release adrenocorticotropic hormone (ACTH)
- ACTH stimulates adrenal cortex to produce cortisol
- Cortisol enters bloodstream and reaches target tissues
- Negative feedback - high cortisol suppresses hypothalamic CRH and pituitary ACTH
- System maintains cortisol at optimal levels through this feedback loop
Cortisol Physiological Functions
Cortisol serves diverse physiological roles:
- Anti-inflammatory action: Baseline suppression of inflammation
- Immune regulation: Modulation of immune responses
- Glucose homeostasis: Gluconeogenesis and blood glucose maintenance
- Stress response: Rises dramatically during stress
- Circadian rhythm: Peak morning, low evening
- Blood pressure regulation: Supports vascular tone
- Bone and mineral metabolism: Affects calcium and bone turnover
- Water and electrolyte balance: Some mineralocorticoid activity
- Muscle and connective tissue: Protein metabolism effects
Synthetic Corticosteroids Superiority
Prednisolone was developed to provide enhanced anti-inflammatory potency compared to cortisol while minimizing mineralocorticoid effects that cause fluid retention. Compared to natural cortisol:
- 4 times more anti-inflammatory potency per milligram
- Reduced mineralocorticoid activity minimizing sodium retention
- Longer biologic half-life enabling less frequent dosing
- Oral bioavailability for convenient administration
- Predictable pharmacokinetics across patients
🧬 Chemistry and Pharmacology of Prednisolone
Prednisolone has the chemical formula C21H28O5 with molecular weight approximately 360.4 g/mol. Structurally, prednisolone is a synthetic pregnane derivative — modified from cortisol structure through addition of a double bond between C1 and C2 which increases anti-inflammatory potency 4-fold while decreasing mineralocorticoid activity. Prednisolone is the active form — unlike prednisone which requires hepatic 11-beta-hydroxysteroid dehydrogenase conversion to prednisolone for pharmacological activity.
Mechanism of Action
Prednisolone mechanism cascade:
- Prednisolone crosses cell membranes via passive diffusion (lipophilic)
- Binds cytoplasmic glucocorticoid receptor in target cells
- Prednisolone-receptor complex translocates to nucleus
- Binds glucocorticoid response elements (GREs) in DNA
-
Modulates transcription of hundreds of genes:
- Suppresses proinflammatory cytokines (TNF-alpha, IL-1, IL-6)
- Induces anti-inflammatory proteins (annexin A1/lipocortin)
- Reduces leukocyte migration and adhesion molecule expression
- Decreases phospholipase A2 activity blocking arachidonic acid release
- Inhibits COX-2 induction
- Reduces antibody production by B lymphocytes
- Induces lymphocyte apoptosis
- Net effects: suppressed inflammation, reduced immune response, glucocorticoid replacement
Pharmacokinetic Profile
| Parameter | Value | Clinical Significance |
|---|---|---|
| Onset of anti-inflammatory effect | Hours (measurable), full effect 24-48 hours | Fast enough for acute severe inflammation |
| Time to peak (Tmax) | 1 to 2 hours | Rapid oral absorption |
| Plasma half-life | 2 to 4 hours | Short plasma half-life |
| Biologic half-life | 12 to 36 hours | Prolonged effects allow once daily dosing |
| Oral bioavailability | Approximately 80 percent | Reliable oral absorption |
| Protein binding | Transcortin (CBG) and albumin, dose dependent | Saturable binding affects free drug at high doses |
| Metabolism | Extensive hepatic CYP3A4 | Numerous drug interactions |
| Anti-inflammatory potency | 4x cortisol equivalent | 5 mg prednisolone equals 20 mg hydrocortisone |
Metabolism and Elimination
Prednisolone undergoes extensive hepatic metabolism primarily through CYP3A4. Metabolites are excreted in urine. Clinical implications include: CYP3A4 inducers (rifampin, phenytoin, carbamazepine) reduce prednisolone levels potentially requiring dose increase, CYP3A4 inhibitors (ketoconazole, ritonavir, macrolides) increase levels potentially requiring dose reduction, and hepatic impairment affects clearance requiring careful dose titration.
🎯 Approved Indications
Deltasone has an extraordinarily broad range of clinical indications reflecting corticosteroid utility across virtually every organ system:
Rheumatologic Diseases
- Rheumatoid arthritis (RA) — flares and low-dose maintenance
- Rheumatism and various rheumatic conditions
- Systemic lupus erythematosus (SLE)
- Polymyalgia rheumatica
- Giant cell arteritis
- Dermatomyositis and polymyositis
- Scleroderma
- Nodular periarteritis (polyarteritis nodosa)
- Various vasculitides
Pulmonary Diseases
- Bronchial asthma exacerbations and severe persistent asthma
- Status asthmaticus requiring urgent therapy
- COPD exacerbations
- Interstitial lung diseases
- Sarcoidosis
Allergic Conditions
- Acute allergic reactions including severe drug allergy
- Chronic allergic conditions
- Anaphylaxis follow-up therapy
- Angioedema
Endocrine Conditions
- Addison disease - primary adrenal insufficiency
- Acute adrenal insufficiency
- Adrenogenital syndrome
Hematologic Conditions
- Immune thrombocytopenic purpura (ITP)
- Autoimmune hemolytic anemia
- Various leukemias as chemotherapy component
- Lymphogranulomatosis (Hodgkin lymphoma) chemotherapy
- Agranulocytosis
- Aplastic anemia
Dermatologic Conditions
- Pemphigus autoimmune bullous disease
- Severe eczema and exfoliative dermatitis
- Psoriasis severe forms
- Seborrheic dermatitis severe
- Erythroderma
- Alopecia autoimmune types
- Pruritus refractory cases
Renal, Hepatic, Neurologic
- Lipoid nephrosis (minimal change nephrotic syndrome)
- Hepatitis autoimmune types
- Hepatic coma in specific situations
- Chorea
- Hypoglycemic conditions requiring corticosteroid support
🚫 Contraindications
Absolute contraindications include:
- Hypersensitivity to prednisolone or corticosteroids
- Systemic fungal infection - unmasked or worsened by immunosuppression
- Live vaccines during high-dose corticosteroid therapy
- Untreated active tuberculosis - may worsen without antitubercular coverage
Use with extreme caution in:
- Active or chronic infections - impaired immune response
- Peptic ulcer disease - increased GI bleeding and perforation risk
- Diabetes mellitus - hyperglycemia effect
- Hypertension - fluid retention and BP elevation
- Congestive heart failure - fluid retention
- Osteoporosis - accelerated bone loss
- Glaucoma - increased intraocular pressure
- Psychiatric disorders - may precipitate psychosis or mood changes
- Pregnancy (Category C/D depending on trimester and use)
- Recent myocardial infarction - potential myocardial rupture
- Renal impairment - fluid retention
- Hepatic impairment - altered metabolism
- Children - growth impairment
- Elderly patients - increased side effects
⚠️ Critical HPA Axis Suppression Warning
Never abruptly discontinue chronic corticosteroid therapy:
Prolonged corticosteroid therapy (typically over 2-3 weeks at doses above physiologic replacement) suppresses the HPA axis. Adrenal glands lose ability to produce cortisol due to negative feedback. If corticosteroids are abruptly discontinued:
- Adrenal crisis may develop (life-threatening)
- Symptoms: severe fatigue, weakness, nausea, vomiting, hypotension, hypoglycemia, shock
- Underlying condition may flare severely
- Death reported in severe cases
Always taper corticosteroid therapy gradually - typically reducing by 5-10 mg every 1-2 weeks for prednisolone, adjusting based on duration of therapy, dose, and clinical response. Longer therapy requires more gradual taper. HPA axis recovery may take months.
💉 Dosage and Administration
Dose Guidelines by Indication
Typical adult dosing ranges:
- Replacement therapy (Addison): 5-7.5 mg daily (5 mg AM + 2.5 mg PM)
- Low-dose maintenance (chronic RA): 5-10 mg daily
- Moderate acute: 20-40 mg daily typically divided
- High-dose severe acute: 40-80 mg daily initially
- Very severe (pemphigus, severe SLE flare): 60-100 mg daily initially
- Asthma exacerbation: 40-60 mg daily for 5-7 days then taper
- Nephrotic syndrome: 60 mg/m2 daily initially then taper
- Rheumatoid arthritis flare: 20-40 mg daily then reduce to maintenance
Standard Tapering Protocols
| Duration of Therapy | Typical Taper Approach |
|---|---|
| Less than 1-2 weeks | May stop abruptly (minimal HPA suppression) |
| 2-4 weeks | Reduce by 5-10 mg every few days |
| 1-3 months | Reduce by 5-10 mg every 1-2 weeks |
| Over 3 months | Reduce by 2.5-5 mg every 2-4 weeks below 20 mg |
| Very long-term | Consider AM cortisol testing before final discontinuation |
Administration Guidelines
- Take in the morning when possible - matches natural cortisol rhythm minimizing HPA suppression
- Take with food or milk - reduces gastric irritation
- For high divided doses give 2/3 in morning, 1/3 in evening
- Do NOT skip doses without medical guidance
- Do NOT abruptly discontinue chronic therapy
- Avoid live vaccines during therapy
- Monitor blood glucose especially if diabetic
- Report all new symptoms promptly
📊 Clinical Effectiveness Data
| Indication | Response Rate |
|---|---|
| Asthma exacerbation response | 90 percent significant improvement in 24-72 hours |
| Rheumatoid arthritis flare | 80-90 percent significant symptom relief |
| Systemic lupus flare | 75-85 percent significant improvement |
| Immune thrombocytopenia (ITP) | 70-80 percent platelet response |
| Minimal change nephrotic syndrome | 85-90 percent complete remission |
| Severe allergic reactions | Rapid symptom resolution |
| Autoimmune hemolytic anemia | 75-85 percent response |
| Pemphigus vulgaris | 80-90 percent response with high-dose therapy |
⚠️ Side Effect Profile
Short-Term Side Effects (Days to Weeks)
- Increased appetite: Very common
- Weight gain: Common with prolonged therapy
- Insomnia: Common
- Mood changes: Elation, irritability, or depression
- Fluid retention and edema: Common
- Elevated blood glucose: Very common in diabetics
- Elevated blood pressure: Common
- Increased susceptibility to infection: Immediate immunosuppression
- Muscle weakness: Common
- Headache: Common
- Facial flushing: Common
Long-Term Side Effects (Weeks to Months)
Serious long-term corticosteroid effects:
- Cushingoid appearance: Moon face, buffalo hump, truncal obesity
- Osteoporosis and fractures: Bone density loss
- Cataracts and glaucoma: Ocular complications
- Diabetes mellitus: Steroid-induced diabetes
- Peptic ulcer disease: Increased GI bleeding risk
- Muscle wasting: Proximal myopathy
- Skin atrophy and easy bruising
- Delayed wound healing
- Adrenal insufficiency: HPA axis suppression
- Growth suppression in children
- Menstrual irregularities
- Hyperlipidemia
- Psychiatric effects: Psychosis, depression, mood disorders
- Increased infection risk: Opportunistic infections
- Avascular necrosis of bone: Rare but devastating
- Aggravation of psychiatric conditions
🔄 Drug Interactions
Major Interactions
| Drug Class | Interaction |
|---|---|
| NSAIDs | Increased GI bleeding and ulcer risk |
| Warfarin | May affect INR either direction - monitor |
| Diabetes medications | Reduced glucose control - may need dose increase |
| CYP3A4 inducers (rifampin, phenytoin, carbamazepine) | Reduced prednisolone levels - may need dose increase |
| CYP3A4 inhibitors (ketoconazole, macrolides) | Increased levels - monitor for adverse effects |
| Live vaccines | Contraindicated during high-dose therapy |
| Digoxin | Hypokalemia from corticosteroid increases toxicity risk |
| Diuretics (loop, thiazide) | Additive hypokalemia |
| Antihypertensives | Reduced effect from corticosteroid BP elevation |
| Bisphosphonates | Recommended combination for chronic therapy - protect bone |
🛡️ Special Populations
- Elderly Patients Over 65
- Increased susceptibility to all side effects particularly osteoporosis, diabetes, hypertension, cataracts, and infections. Use lowest effective dose for shortest duration. Consider bone protection with calcium, vitamin D, and bisphosphonates. Monitor blood glucose, BP, and bone density.
- Pediatric Population
- Growth impairment concern with prolonged use. Use weight-based dosing. Monitor growth carefully during and after therapy. Alternate day dosing may reduce growth effects. Bone health monitoring important.
- Pregnancy
- Category C in first trimester (increased cleft palate risk), Category D in later trimesters. Use only if clearly indicated. Prednisolone crosses placenta less than dexamethasone. Newborn HPA suppression possible with prolonged maternal use.
- Lactation
- Small amounts in breast milk. Generally considered compatible with breastfeeding at doses under 20 mg daily. Higher doses monitor infant for HPA suppression.
- Diabetic Patients
- Corticosteroids cause hyperglycemia. Monitor blood glucose closely. Diabetes medications may need adjustment. Insulin may be required temporarily. Adjust down as steroid dose reduces.
- Hypertensive Patients
- Fluid retention and BP elevation common. Monitor BP regularly. Antihypertensive adjustment may be needed.
- Patients with Infection Risk
- Immunosuppression increases infection risk. Screen for latent TB before chronic therapy. Prophylaxis considerations for Pneumocystis jirovecii with high-dose therapy.
- Osteoporosis Risk Patients
- Postmenopausal women, elderly, chronic therapy patients. Bone protection with calcium, vitamin D, and bisphosphonates recommended for therapy expected over 3 months.
🔬 Comparison with Other Corticosteroids
| Corticosteroid | Equivalent Dose | Duration | Best For |
|---|---|---|---|
| Hydrocortisone (cortisol) | 20 mg | Short (8-12h) | Adrenal replacement, IV acute |
| Prednisolone (Deltasone) | 5 mg | Intermediate (12-36h) | General workhorse |
| Prednisone | 5 mg | Intermediate (12-36h) | US equivalent (needs liver conversion) |
| Methylprednisolone | 4 mg | Intermediate (12-36h) | IV therapy (pulse dosing) |
| Dexamethasone | 0.75 mg | Long (36-72h) | Cerebral edema, oncology, COVID |
| Triamcinolone | 4 mg | Intermediate | Intra-articular injection |
📆 Long-Term Use Considerations
Chronic corticosteroid therapy monitoring:
- Blood glucose: Regular monitoring for steroid-induced diabetes
- Blood pressure: Every visit
- Bone density (DEXA): Baseline and every 1-2 years
- Bone protection: Calcium 1000-1500 mg + vitamin D 800-1000 IU daily
- Bisphosphonate: Consider for chronic doses above 7.5 mg for over 3 months
- Eye exams: Annually for cataracts and glaucoma
- Lipid panel: Baseline and periodic
- Weight and body composition: Regular monitoring
- PPI or H2 blocker: If concurrent NSAID or high-dose therapy
- Vaccination status: Update before therapy - inactivated only during
- TB screening: Before initiation of chronic therapy
- PJP prophylaxis: Consider with high-dose therapy above 20 mg for 4+ weeks
📦 Storage and Handling
- Store at room temperature between 15°C and 30°C (59°F and 86°F)
- Keep in original blister packaging to protect from light and moisture
- Avoid storage in bathrooms where humidity fluctuates significantly
- Keep out of reach of children and pets
- Do not use tablets past the expiration date printed on packaging
- Return unused or expired medication to pharmacy for proper disposal
- Never share corticosteroids with others as doses and safety considerations vary dramatically
- Maintain adequate supply for chronic therapy to prevent interruption and HPA crisis
👨⚕️ When to Contact Your Doctor
- Signs of infection: fever, chills, sore throat, unusual fatigue
- Severe mood changes, depression, or psychotic symptoms
- Signs of GI bleeding: black stools, vomiting blood, severe abdominal pain
- Signs of adrenal crisis if therapy interrupted: severe fatigue, nausea, weakness, low BP
- Blood glucose elevations or new diabetes
- Blood pressure elevations
- Vision changes suggesting glaucoma or cataract
- Severe muscle weakness or bone pain
- New fractures or bone injuries suggesting osteoporosis
- Excessive weight gain or Cushingoid appearance
- Persistent skin bruising or delayed wound healing
- Signs of allergic reaction to medication
- Pregnancy planning or confirmed pregnancy
- Upcoming surgery or dental procedure
- Starting any new medications especially NSAIDs, live vaccines, CYP3A4 modifiers
- Symptoms of underlying disease flare during taper
- Any acute severe illness requiring stress-dose steroid consideration
🌟 Key Takeaways
Essential points about Deltasone (prednisolone) therapy:
- Deltasone is foundational synthetic glucocorticoid corticosteroid since 1955
- Works through glucocorticoid receptor activation modulating hundreds of gene expressions
- 4-fold anti-inflammatory potency of natural cortisol with less mineralocorticoid effect
- Take in the morning with food to match natural cortisol rhythm and reduce GI upset
- Effective across dozens of conditions in nearly every medical specialty
- Four dose strengths (5, 10, 20, 40 mg) enable precise dose titration
- Never abruptly discontinue chronic therapy - always taper gradually
- HPA axis suppression develops with therapy over 2-3 weeks at physiologic doses
- Multiple side effects including diabetes, hypertension, osteoporosis, infections, cataracts
- Bone protection recommended for chronic therapy above 7.5 mg for over 3 months
- Multiple drug interactions particularly with NSAIDs, CYP3A4 modifiers, live vaccines
- Contraindicated with systemic fungal infection, live vaccines, active TB (untreated)
- Regular monitoring of BP, glucose, bone density, and eyes essential during chronic use
- Growth suppression concern in children requires careful monitoring
Important Medical Disclaimer: This medication guide provides general information about Deltasone (prednisolone) and does not constitute individualized medical advice. Every patient situation is unique and requires evaluation by a qualified healthcare provider before starting continuing adjusting or discontinuing any medication. Do not use Deltasone without prescription from a qualified healthcare professional who has evaluated your specific medical situation and confirmed appropriate patient selection. NEVER abruptly discontinue chronic corticosteroid therapy - always taper gradually under medical supervision to prevent potentially life-threatening adrenal insufficiency. Report immediately signs of infection, GI bleeding, adrenal crisis, or severe adverse effects. Corticosteroid therapy requires ongoing monitoring for numerous potential side effects. If you experience concerning symptoms contact your healthcare provider promptly. The information provided here should complement but never replace direct professional medical guidance.
Deltasone — Frequently Asked Questions
-
What is Deltasone (Prednisolone)?
Deltasone is a corticosteroid medication used to treat a wide range of inflammatory and autoimmune conditions. -
How does Deltasone work?
It works by suppressing the immune system and reducing inflammation. -
What conditions does Deltasone treat?
It's used for arthritis, asthma, allergic reactions, autoimmune diseases, skin conditions, and certain blood disorders. -
How quickly does Deltasone start working?
The effects can be noticed within a few hours, but it may take a few days to see the full benefit. -
How long do the effects of Deltasone last?
The duration of effect varies depending on the condition being treated and the dosage. -
Can Deltasone be used for general pain relief?
It's not typically used for general pain unless associated with inflammation. -
What are the side effects of Deltasone?
Common side effects include increased appetite, weight gain, insomnia, and mood changes.
See all Deltasone questions (32)
More Pain Medicine Medications
